About
Scope & Aims
Editorial office
Editorial board
Reviewers
Ethical standards and procedures
Abstracting and indexing
Contact
Articles & Issues
Current issue
Articles in press
Archive
For Authors
General rules
Ethics in publishing
Guide for authors
Templates
Publication charge
For Reviewers
Our reviewers
Ethics in publishing
Guide for reviewers
Books and Events
Books
Events
REVIEW PAPER
Effect of electromagnetic field therapy in chronic respiratory disease: systematic review
1
Department of Physiotherapy, Integral University, Lucknow, India
2
Department of Rehabilitation, School of Nursing Sciences and Allied Health, Jamia Hamdard, Delhi, India
Submission date: 2023-03-02
Acceptance date: 2023-05-25
Publication date: 2024-06-21
Physiother Quart. 2024;32(2):19-24
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Pulmonary function and functional capacity decline in chronic respiratory diseases, especially in chronic obstructive pulmonary disease. Physiotherapy is an integral part of treating respiratory patients since it helps combat muscle depletion and respiratory symptoms. Nevertheless, the knowledge about applying electromagnetic field (EMF) therapy as a therapeutic option in chronic respiratory patients is minimal. So, the aim of this review is to determine the effect of Electromagnetic Field Therapy on Pulmonary Function and 6-minute walk distance in chronic respiratory disease patients.
Methods:
The PubMed, PeDRO, Scopus, COCHRANE, and Web of Science databases were searched and randomised control trials investigating EMF on pulmonary function and 6MWT distance in a chronic respiratory disease population, published before January 2022, were selected. Three reviewers assessed each study’s quality after data were extracted into a trial description form.
Results:
Three studies met the inclusion criteria on pulmonary function and 6MWT distance. The sample size ranges from 10 to 37 for EMF. The improvement in pulmonary function was not significant in FEV1, FEV1/FVC and significant in PEF versus control. The change in 6MWT distance was 21.68 m, which is a clinically significant change.
Conclusions:
EMF therapy has been shown to improve pulmonary function and 6MWT distance. The study was the first to examine and synthesise existing EMF data.
Pulmonary function and functional capacity decline in chronic respiratory diseases, especially in chronic obstructive pulmonary disease. Physiotherapy is an integral part of treating respiratory patients since it helps combat muscle depletion and respiratory symptoms. Nevertheless, the knowledge about applying electromagnetic field (EMF) therapy as a therapeutic option in chronic respiratory patients is minimal. So, the aim of this review is to determine the effect of Electromagnetic Field Therapy on Pulmonary Function and 6-minute walk distance in chronic respiratory disease patients.
Methods:
The PubMed, PeDRO, Scopus, COCHRANE, and Web of Science databases were searched and randomised control trials investigating EMF on pulmonary function and 6MWT distance in a chronic respiratory disease population, published before January 2022, were selected. Three reviewers assessed each study’s quality after data were extracted into a trial description form.
Results:
Three studies met the inclusion criteria on pulmonary function and 6MWT distance. The sample size ranges from 10 to 37 for EMF. The improvement in pulmonary function was not significant in FEV1, FEV1/FVC and significant in PEF versus control. The change in 6MWT distance was 21.68 m, which is a clinically significant change.
Conclusions:
EMF therapy has been shown to improve pulmonary function and 6MWT distance. The study was the first to examine and synthesise existing EMF data.
REFERENCES (29)
1.
GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–544; doi: 10.1016/S0140-6736(16)31012-1.
2.
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–602; doi: 10.1016/S0140-6736(16)31678-6.
3.
Ross CL, Zhou Y, McCall CE, Soker S, Criswell TL. The Use of pulsed electromagnetic field to modulate inflammation and improve tissue regeneration: a review. Bioelectricity. 2019;1(4):247–259; doi: 10.1089/bioe.2019.0026.
4.
Paolucci T, Piccinini G, Iosa M, Piermattei C, de Angelis S, Grasso MR, Zangrando F, Saraceni VM. Efficacy of extremely low-frequency magnetic field in fibromyalgia pain: a pilot study. J Rehabil Res Dev. 2016;53(6):1023–1034; doi: 10.1682/JRRD.2015.04.0061.
5.
Cichoń N, Bijak M, Miller E, Saluk J. Extremely low frequency electromagnetic field (ELF-EMF) reduces oxidative stress and improves functional and psychological status in ischemic stroke patients. Bioelectromagnetics. 2017;38(5):386–96; doi: 10.1002/bem.22055.
6.
Kanat E, Alp A, Yurtkuran M. Magnetotherapy in hand osteoarthritis: a pilot trial. Complement Ther Med. 2013;21(6):603–608; doi: 10.1016/j.ctim.2013.08.004.
7.
Sieroń A, Cieślar G. Application of variable magnetic fields in medicine – 15 years experience. Wiad Lek. 2003;56(9–10):434–41.
8.
Servodio Iammarrone C, Cadossi M, Sambri A, Grosso E, Corrado B, Servodio Iammarrone F. Is there a role of pulsed electromagnetic fields in management of patellofemoral pain syndrome? Randomized controlled study at one year follow-up. Bioelectromagnetics. 2016; 37(2):81–88; doi: 10.1002/bem.21953.
9.
Sadlonova J, Korpas J, Vrabec M, Salat D, Buchancova J, Kudlicka J. The effect of the pulsatile electromagnetic field in patients suffering from chronic obstructive pulmonary disease and bronchial asthma. Bratisl Lek Listy. 2002;103(7–8):260–65.
10.
Tenforde TS, Kaune WT. Interaction of extremely low frequency electric and magnetic fields with humans. Health Phys. 1987;53(6):585–606; doi: 10.1097/00004032-198712000-00002.
11.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–12; doi: 10.1016/j.ijsu.2010.02.007.
12.
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011; 343:d5928; doi: 10.1136/bmj.d5928.
13.
Higgins JPT, Green S. Assessing risk of bias in included studies. In: Cochrane Handbook for Systematic Reviews of Interventions; 2008:187–241; doi: 10.1136/bmj.d5928.
14.
Herbert R, Moseley A, Sherrington C, Maher C. Physiotherapy evidence database. Physiotherapy. 2000;86:55; doi: 10.1016/s0004-9514(14)60281-6.
15.
Bustamante V, de Santa María EL, Gorostiza A, Jiménez U, Gáldiz JB. Muscle training with repetitive magnetic stimulation of the quadriceps in severe COPD patients. Respir Med. 2010;104(2):237–45; doi: 10.1016/j.rmed.2009.10.001.
16.
Bustamante V, Casanova J, López de Santamaria E, Mas S, Sellares J, Gea J, Gáldiz JB, Barreiro E. Redox balance following magnetic stimulation training in the quadriceps of patients with severe COPD. Free Radic Res. 2008;42(11–12):939–48; doi: 10.1080/10715760802555569.
17.
Sadlonova J, Korpas J. The effect of the pulsatile electromagnetic field in children suffering from bronchial asthma. Acta Physiol Hungarica; 2003;90(4):327–334. doi: 10.1556/APhysiol.90.2003.4.6.
18.
Vallbona C, Richards T. Evolution of magnetic therapy from alternative to traditional medicine. Phys Med Rehabil Clin N Am. 1999;10(3):729–54.
19.
Borg MJ, Marcuccio F, Poerio AM, Vangone A. Magnetic fields in physical therapy. Experience in orthopedics and traumatology rehabilitation. Minerva Med. 1996;87(10):495–97.
20.
Sadlonova J, Korpas J. Personal experience in the use of magnetotherapy in diseases of the musculoskeletal system. Bratisl Lek Listy. 1999;100(12):678–681.
21.
Bisca GW, Camillo CA, Cavalheri V, Pitta F, Osadnik CR. Peripheral muscle training in patients with chronic obstructive pulmonary disease: novel approaches and recent advances. Expert Rev Respir Med. 2017;11(5):413–23; doi: 10.1080/17476348.2017.1317598.
22.
Katajisto M, Laitinen T. Estimating the effectiveness of pulmonary rehabilitation for COPD exacerbations: reduction of hospital inpatient days during the following year. Int J Chron Obstruct Pulmon Dis. 2017;12:2763–69; doi: 10.2147/COPD.S144571.
23.
Blánquez Moreno C, Colungo Francia C, Alvira Balada MC, Kostov B, González-de Paz L, Sisó-Almirall A. Effectiveness of an educational program for respiratory rehabilitation of Chronic Obstructive Pulmonary Disease patients in Primary Care in improving the quality of life, symptoms, and clinical risk. Aten Primaria. 2018;50(9):539–46; doi: 10.1016/j.aprim.2017.03.019.
24.
Lalmolda C, Coll-Fernández R, Martínez N, Baré M, Teixidó Colet M, Epelde F, Monsó E. Effect of a rehabilitation-based chronic disease management program targeting severe COPD exacerbations on readmission patterns. Int J Chron Obstruct Pulmon Dis. 2017;12:2531–38; doi: 10.2147/COPD.S138451.
25.
Polastri M, Pisani L, Dell’Amore A, Nava S. Revolving door respiratory patients: a rehabilitative perspective. Monaldi Arch Chest Dis Arch. 2017;87(3):857; doi: 10.4081/monaldi.2017.857.
26.
Higashimoto Y, Ando M, Sano A, Saeki S, Nishikawa Y, Fukuda K, Tohda Y. Effect of pulmonary rehabilitation programs including lower limb endurance training on dyspnea in stable COPD: a systematic review and meta-analysis. Respir Investig. 2020;58(5):355–66; doi: 10.1016/j.resinv.2020.05.010.
27.
Hill K, Cavalheri V, Mathur S, Roig M, Janaudis-Ferreira T, Robles P, Dolmage TE, Goldstein R. Neuromuscular electrostimulation for adults with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2018;5(5):CD010821; doi: 10.1002/14651858.
28.
Wu X, Hu X, Hu W, Xiang G, Li S. Effects of neuromuscular electrical stimulation on exercise capacity and quality of life in COPD patients: a systematic review and meta-analysis. Biosci Rep. 2020;40(5):BSR20191912; doi: 10.1042/BSR20191912.
29.
Alves IGN, da Silva E Silva CM, Martinez BP, de Queiroz RS, Gomes-Neto M. Effects of neuromuscular electrical stimulation on exercise capacity, muscle strength and quality of life in COPD patients: a systematic review with meta-analysis. Clin Rehabil. 2022;36(4):449–71; doi: 10.1177/02692155211067983.
Share
RELATED ARTICLE
| eISSN: | 2544-4395 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
